Key Takeaways Among adults with recently diagnosed Parkinson’s disease, those with concomitant type 2 diabetes had at study entry more

Agents that form the sodium-glucose cotransporter 2 inhibitor class – including canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance) – have

It’s important to be alert for signs that a person with diabetes might be among the minority, of around 5%,

Nearly half of adults prescribed metformin after a new diagnosis of type 2 diabetes have stopped taking it by 1

Tirzepatide, a novel “twincretin” agent, was superior to 1-mg semaglutide treatments for reducing both hemoglobin A1c levels and body weight